26 Recruiting Advanced Cancer Phase 1 Clinical Trials
Active phase 1 studies for advanced cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced Cancer studiesPhase 1 Studies for Advanced Cancer
FS120 Phase 1/1b Study in Patients With Advanced Malignancies
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
📍 California Cancer Associates for Research and Excellence — Encinitas, California
View Study & Checklist ➔Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
📍 Local Institution - 001-826 — Birmingham, Alabama
View Study & Checklist ➔Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Assessing the Immunogenicity of pING-hHER3FL
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
📍 Banner MD Anderson — Gilbert, Arizona
View Study & Checklist ➔Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
📍 Research Site — Denver, Colorado
View Study & Checklist ➔Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors
📍 D&H Cancer Research Center Llc — Margate, Florida
View Study & Checklist ➔A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
📍 Valkyrie Clinical Trials — Los Angeles, California
View Study & Checklist ➔Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
📍 Case Western Reserve University — Cleveland, Ohio
View Study & Checklist ➔A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
📍 University of Colorado Cancer Center — Aurora, Colorado
View Study & Checklist ➔A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
View Study & Checklist ➔A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Phase 1/2 Study of UI-102 in Selected Advanced Cancers
📍 NEXT Oncology — Dallas, Texas
View Study & Checklist ➔A Study in Patients With Advanced Cancers
📍 NEXT Oncology Austin — Austin, Texas
View Study & Checklist ➔SLV-154 Treatment of Advanced Cancers
📍 Hoag Memorial Hospital Presbyterian — Newport Beach, California
View Study & Checklist ➔Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
📍 Denver Drug Development Unit — Denver, Colorado
View Study & Checklist ➔